These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 12210228)

  • 1. Apolipoprotein E and other cerebrospinal fluid proteins differentiate ante mortem variant Creutzfeldt-Jakob disease from ante mortem sporadic Creutzfeldt-Jakob disease.
    Choe LH; Green A; Knight RS; Thompson EJ; Lee KH
    Electrophoresis; 2002 Jul; 23(14):2242-6. PubMed ID: 12210228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease.
    Brechlin P; Jahn O; Steinacker P; Cepek L; Kratzin H; Lehnert S; Jesse S; Mollenhauer B; Kretzschmar HA; Wiltfang J; Otto M
    Proteomics; 2008 Oct; 8(20):4357-66. PubMed ID: 18814332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid.
    Collins S; Boyd A; Fletcher A; Gonzales M; McLean CA; Byron K; Masters CL
    J Clin Neurosci; 2000 May; 7(3):203-8. PubMed ID: 10833616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of potential cerebrospinal fluid molecular markers for Alzheimer's disease.
    Choe LH; Dutt MJ; Relkin N; Lee KH
    Electrophoresis; 2002 Jul; 23(14):2247-51. PubMed ID: 12210229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.
    Van Everbroeck B; Boons J; Cras P
    Clin Neurol Neurosurg; 2005 Aug; 107(5):355-60. PubMed ID: 16023527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis of the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
    Cepek L; Brechlin P; Steinacker P; Mollenhauer B; Klingebiel E; Bibl M; Kretzschmar HA; Wiltfang J; Otto M
    Dement Geriatr Cogn Disord; 2007; 23(1):22-8. PubMed ID: 17068393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CSF-analyses in clinical diagnosis of Creutzfeldt-Jakob disease. A literature review and three cases from routine clinical practice].
    Blennow K; Lind B; Andersson E; Andreasen N
    Lakartidningen; 2001 May; 98(20):2446-51. PubMed ID: 11433975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
    Harrington MG; Merril CR; Asher DM; Gajdusek DC
    N Engl J Med; 1986 Jul; 315(5):279-83. PubMed ID: 3523251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical algorithm for cerebrospinal fluid test of 14-3-3 protein in diagnosis of Creutzfeldt-Jacob disease].
    Lemstra AW; van Meegen M; Baas F; van Gool WA
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1467-71. PubMed ID: 11503317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Searching for markers of Creutzfeldt-Jakob disease in cerebrospinal fluid by two-dimensional mapping.
    Piubelli C; Fiorini M; Zanusso G; Milli A; Fasoli E; Monaco S; Righetti PG
    Proteomics; 2006 Apr; 6 Suppl 1():S256-61. PubMed ID: 16511811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin as potential cerebrospinal fluid marker of Creutzfeldt-Jakob disease.
    Steinacker P; Rist W; Swiatek-de-Lange M; Lehnert S; Jesse S; Pabst A; Tumani H; von Arnim CA; Mitrova E; Kretzschmar HA; Lenter M; Wiltfang J; Otto M
    Proteomics; 2010 Jan; 10(1):81-9. PubMed ID: 19882659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease.
    Pennington C; Chohan G; Mackenzie J; Andrews M; Will R; Knight R; Green A
    Neurosci Lett; 2009 May; 455(1):56-9. PubMed ID: 19429106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-amyloid peptides in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
    Wiltfang J; Esselmann H; Smirnov A; Bibl M; Cepek L; Steinacker P; Mollenhauer B; Buerger K; Hampel H; Paul S; Neumann M; Maler M; Zerr I; Kornhuber J; Kretzschmar HA; Poser S; Otto M
    Ann Neurol; 2003 Aug; 54(2):263-7. PubMed ID: 12891683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14-3-3 in the cerebrospinal fluid of patients with variant and sporadic Creutzfeldt-Jakob disease measured using capture assay able to detect low levels of 14-3-3 protein.
    Green AJ; Ramljak S; Müller WE; Knight RS; Schröder HC
    Neurosci Lett; 2002 May; 324(1):57-60. PubMed ID: 11983294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid.
    Zerr I; Bodemer M; Otto M; Poser S; Windl O; Kretzschmar HA; Gefeller O; Weber T
    Lancet; 1996 Sep; 348(9031):846-9. PubMed ID: 8826809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease.
    Sanchez-Juan P; Green A; Ladogana A; Cuadrado-Corrales N; Sáanchez-Valle R; Mitrováa E; Stoeck K; Sklaviadis T; Kulczycki J; Hess K; Bodemer M; Slivarichová D; Saiz A; Calero M; Ingrosso L; Knight R; Janssens AC; van Duijn CM; Zerr I
    Neurology; 2006 Aug; 67(4):637-43. PubMed ID: 16924018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease.
    Geschwind MD; Martindale J; Miller D; DeArmond SJ; Uyehara-Lock J; Gaskin D; Kramer JH; Barbaro NM; Miller BL
    Arch Neurol; 2003 Jun; 60(6):813-6. PubMed ID: 12810484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.
    Hsich G; Kenney K; Gibbs CJ; Lee KH; Harrington MG
    N Engl J Med; 1996 Sep; 335(13):924-30. PubMed ID: 8782499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias.
    Riemenschneider M; Wagenpfeil S; Vanderstichele H; Otto M; Wiltfang J; Kretzschmar H; Vanmechelen E; Förstl H; Kurz A
    Mol Psychiatry; 2003 Mar; 8(3):343-7. PubMed ID: 12660807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease.
    Buerger K; Otto M; Teipel SJ; Zinkowski R; Blennow K; DeBernardis J; Kerkman D; Schröder J; Schönknecht P; Cepek L; McCulloch C; Möller HJ; Wiltfang J; Kretzschmar H; Hampel H
    Neurobiol Aging; 2006 Jan; 27(1):10-5. PubMed ID: 16298235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.